Print Page

Products found to contain undeclared medicines

Australia: Safety Advisory: Body Con Plus capsules found to contain the undeclared substances sibutramine and phenolphthalein
The Therapeutic Goods Administration (TGA) has tested a product labelled Body Con Plus capsules and found that the capsules contain the undeclared substances sibutramine and phenolphthalein. TGA investigations have shown that a number of people in Australia may have bought the product online. Consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). It was withdrawn in October 2010 after a study showed an increased risk of major cardiac events. Phenolphthalein is a prescription-only substance previously marketed as an oral laxative, withdrawn from sale from many markets in the late 1990's due to concerns over its carcinogenicity with long term use. Consumers should stop taking the product and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of the product, consult their health care practitioner.

Please refer to the following website in TGA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Tuesday, Sep 19, 2017
Issued at HKT 15:00
Related Information:
Canada: Foreign Product Alert: Body Con Plus capsules, Physic Candy - Define, 7-... Posted 2017-10-30
Australia: Safety Advisory: 7-Day Slim Extreme capsules found to contain the und... Posted 2017-09-19
The United States: Public Notification: Physic Candy – Define contains hidden dr... Posted 2017-09-01